Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-21-020653
Filing Date
2021-06-11
Accepted
2021-06-11 16:17:52
Documents
5
Effectiveness Date
2021-06-11

Document Format Files

Seq Description Document Type Size
1 S-8 nt10025602x1_s-8.htm S-8 60141
2 EXHIBIT 5.1 nt10025602x1_ex5-1.htm EX-5.1 7070
3 EXHIBIT 23.2 nt10025602x1_ex23-2.htm EX-23.2 2713
4 nt10025602x1_ex5-1image01.jpg GRAPHIC 1768
5 nt10025602x1_ex5-1image02.jpg GRAPHIC 7250
  Complete submission text file 0001140361-21-020653.txt   83901
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

EIN.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-257029 | Film No.: 211011493
SIC: 2834 Pharmaceutical Preparations